canakinumab - Medications

Browse 6 medications containing canakinumab. Open a product record to review formulation details, related brands, manufacturers, and label-backed information.

CITOMIX ALDESLEUKIN BINETRAKIN CANAKINUMAB CENTELLA ASIATICA CRANBERRY HUMAN INTERLEUKIN 6 NONGLYCOSYLATED INTERFERON GAMMA 1B LENOGRASTIM PINEAPPLE SUS SCROFA BONE MARROW SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE SUS SCROFA THYMUS

Immune support suring times of: Seasonal colds and flu

GUNA-ANTI IL 1 ANTI INTERLEUKIN 1.ALPHA. IMMUNOGLOBULIN G RABBIT CANAKINUMAB

Take 15 minutes before meals.

GUNA-DERMO ALDESLEUKIN ARSENIC TRIOXIDE ATROPA BELLADONNA CANAKINUMAB ECHINACEA ANGUSTIFOLIA GRAPHITE MELATONIN PLANTAGO MAJOR SOLANUM DULCAMARA FLOWER SULFUR

Take 15 minutes before meals

GUNA-HEMORRHOIDS ACTIVATED CHARCOAL ARNICA MONTANA ATROPA BELLADONNA CANAKINUMAB HYDROCOTYLE ASIATICA EXTRACT AESCULUS HIPPOCASTANUM FLOWER MELISSA OFFICINALIS PAEONIA OFFICINALIS ROOT PODOPHYLLUM PELTATUM ROOT PORK LIVER STRYCHNOS NUX VOMICA SEED SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE SUS SCROFA VEIN HAMAMELIS VIRGINIANA ROOT BARK STEM BARK ANTI INTERLEUKIN 1.ALPHA. IMMUNOGLOBULIN G RABBIT

Take 15 minutes before meals.

GUNA-SLEEP AVENA SATIVA FLOWERING TOP CANAKINUMAB CHAMOMILE HELLEBORUS NIGER ROOT MELATONIN MELISSA OFFICINALIS PULSATILLA VULGARIS SEROTONIN STRYCHNOS IGNATII SEED SUS SCROFA PINEAL GLAND VALERIAN

Take 15 minutes before meals.

Ilaris CANAKINUMAB
(CANAKINUMAB) 150 mg/ml Injection
NOVARTIS PHARMACEUTICALS CORPORATION FDA Rx Only

Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs to the IgG1/κ isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). The biological activity of canakinumab is measured by comparing its inhibition of IL-1β-dependent expression of the reporter gene luciferase to that of a canakinumab internal reference standard, using a stably transfected cell line. ILARIS Injection ILARIS (canakinumab) Injection is supplied as a sterile, preservative-free, clear to opalescent, colorless to slightly brownish-yellow solution for subcutaneous injection in a single-dose, glass vial with coated stopper and aluminum flip-off cap. Each vial delivers 1 mL containing 150 mg canakinumab, L-histidine (2.1 mg), L-histidine HCl monohydrate (1.3 mg), mannitol (49.2 mg), polysorbate 80 (0.4 mg), and Sterile Water for Injection.

About canakinumab

This collection groups medications in our database that include canakinumab. It currently includes 6 matching listings. Open a result to review formulation details, related brands, manufacturers, and product labels.

What You Can Review

Use this page to find products that share the same indexed ingredient name, then open drug detail pages for dosage, labeling, and related navigation.

Safety Information

Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice.

Medical Tools & Resources

← Back to search